Jill Waibel is a Dermatology physician affiliated with Baptist Hospital of Miami. OpenAlex indexes 116 publications with 3,248 citations (h-index 27); ClinicalTrials.gov lists 3 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
7800 SW 87th Ave
Suite B200
Miami, FL 331733570
Telephone
305-279-6060Registry record last updated 13 Aug 2014.
Clinical trials
- Nonablative Fractional Diode Laser for Treatment of Pigmented Lesions
Sponsor: Candela Corporation
- Safety and Efficacy Study for Various Skin Conditions
Sponsor: Sciton
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
42 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Solta Medical, a division of Bausch Health US, LLCProgram year20253 payments$17,124openpaymentsdata.cms.gov ↗
- Eli Lilly and CompanyProgram year20253 payments
- Galderma Laboratories, L.P.Program year20259 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
50.4%Tetracycline-class Drug18.5%Doxycycline Hyclate100%Part D≥62 patientsAzole Antifungal15.9%Fluconazole100%Part D≥59 patients+ 1 more class in this area
Sensory organs
32.7%Aminoglycoside Antibacterial26.5%Gentamicin Sulfate100%Part D≥92 patientsCorticosteroid6.2%Betamethasone Dipropionate55%Clobetasol Propionate45%Part D≥13 patientsMetabolism & gastrointestinal
7.8%Corticosteroid7.8%Prednisone100%Part D≥19 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Similar KOLs
Other experts from the same institution or the same specialty.
Guilherme Rabinowits, MD
Baptist Hospital of Miami
Lyle Feinstein, MD
Baptist Hospital of Miami
Horacio Asbun, MD
Baptist Hospital of Miami
Barry Katzen, MD
Baptist Hospital of Miami
Robert Modlin, MD
University of California, Los Angeles
Heidi Kong, MD
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Jon Hanifin, MD
Oregon Health & Science University (OHSU)
Victoria Werth, MD
Perelman School of Medicine at the University of Pennsylvania
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”